期刊
EXPERT REVIEW OF PROTEOMICS
卷 3, 期 2, 页码 237-249出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14789450.3.2.237
关键词
2D electrophoresis; biomarker candidate; cardiovascular disease; glycome; interactome; multidimensional liquid chromatography; multiplex immune assay; peptidome; plasma; proteomic pattern; proteomics; serum; subproteome
资金
- NHLBI NIH HHS [P50 HL084946-019003, P50 HL084946-039003, N0-HV-28180, P50 HL084946, P50 HL084946-029003, N01 HV028180] Funding Source: Medline
Cardiovascular disease is the leading cause of mortality and morbidity in the industrialized world. Total worldwide deaths due to this disease are currently estimated at 17 million per year, and this number is expected to increase over the next several decades. To address this epidemic, a major effort has begun to develop new cardiovascular disease markers through the use of proteomic analysis, the global study of proteins. This review discusses strategies, recent technological advances and other issues in plasma/serum biomarker discovery for cardiovascular diseases. Emphasis lies on the needs for standardizing specimen collection, methods for reducing plasma proteome complexity to subproteomes, selection of appropriate technology platforms and strategies to evaluate candidates by multiplexed immune assays. The overall goal of this effort is to identify serum biomarkers for diagnosis, therapeutic monitoring and risk stratification of cardiovascular diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据